EP3648788
TREATMENT OF GASTROINTESTINAL BLEEDING IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE BY ADMINISTRATION OF RECOMBINANT VWF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.7.2018EP published:
22.5.2024EP application number:
18746458.1
EPO information:
European Patent Register
Max expiry date:
8.7.2038
Title in English:
TREATMENT OF GASTROINTESTINAL BLEEDING IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE BY ADMINISTRATION OF RECOMBINANT VWFLanguage of the patent:
English
Timeline
Today
9.7.2018EP application
22.5.2024EP Publication
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, JP
Inventor
Name:
CHAPMAN, MirandaAddress:
Wellesley, MA 02482, US
Name:
EWENSTEIN, BruceAddress:
Brookline, MA 02445, US
Name:
PLODER, BettinaAddress:
1220 Vienna, AT
Priority
Number:
201762530027 PDate:
7.7.2017Country:
US
Classification
Categories:
A61K 38/36, A61K 38/37, A61P 7/04